The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Open accessAbstract
Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated, is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy. Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“modeling studies performed on the mutational data have estimated that the timeline of multistep progression to invasive neoplasia in the pancreas likely spans multiple years and provides a theoretically wide window of opportunity for early detection27.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [27]
In the citing paper
“Pancreatic tumours are highly heterogeneous, both within and between individuals.66,67”
From Early detection of pancreatic cancer (2020) · cites this paper as [67]
In the citing paper
“It is now appreciated that most clinically relevant solid tumors are highly heterogeneous at the phenotypic, physiologic, and genomic levels (13–15) and that they continue to evolve over time.”
From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Self-citationCore Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationMetastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,716
Isaacson, P. G., Doǧan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,913
Comparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Tibor Antal, A., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 827
Self-citationAdvanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Self-citationMaitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,006
Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma
Unger, K. R., Mehta, K. Y., Kaur, P., Wang, Y., Menon, S. S., Jain, S. K., Moonjelly, R. A., Suman, S., Datta, K., Singh, R., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25212 · Cited by 43
Qian, Z., Li, Y., Sun, Z., Fan, X., Xu, K., Wang, K., Li, S., Zhang, Z., Jiang, T., Liu, X., et al. (2018) · Aging · doi:10.18632/aging.101594 · Cited by 43
Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression
Hadden, M. K., Mittal, A., Samra, J. S., Zreiqat, H., Sahni, S., & Ramaswamy, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188418 · Cited by 40
Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
Wu, Y., Biswas, D., & Swanton, C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.013 · Cited by 43
Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression
Mohammed, A., Janakiram, N. B., Madka, V., Brewer, M. F., Ritchie, R. L., Lightfoot, S. A., Kumar, G., Sadeghi, M., Patlolla, J. M. R., Yamada, H. Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3499 · Cited by 39
Next-generation sequencing applied to molecular diagnostics
Natrajan, R., & Reis-Filho, J. S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.18 · Cited by 41
Al‐Ejeh, F., Pajic, M., Shi, W., Kalimutho, M., Miranda, M. S., Nagrial, A. M., Chou, A. S. Y., Biankin, A. V., Grimmond, S. M., Initiative, F. T. A. P. C. G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0048 · Cited by 39
Josephidou, M., Lynch, A. G., & Tavaré, S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv135 · Cited by 39
Wang, Y., Sushil Kumar, K., Rachagani, S., Sajja, B. R., Xie, Y., Yu, H., Jain, M., Li, J., Boska, M. D., Batra, S. K., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.042 · Cited by 39
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 39
Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials
Jiang, M., Dai, J., Gu, D.-N., Huang, Q., & Tian, L. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.08.002 · Cited by 39
New insights into the earliest stages of colorectal tumorigenesis
Sievers, C. K., Grady, W. M., Halberg, R. B., & Pickhardt, P. J. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1330150 · Cited by 40
CRISPR/Cas9 for overcoming drug resistance in solid tumors
Saber, A., Liu, B., Ebrahimi, P., & Haisma, H. J. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00240-z · Cited by 45
Cancer recurrence times from a branching process model
Avanzini, S., & Tibor Antal, A. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007423 · Cited by 42
Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion
Tekin, C., Aberson, H. L., Bijlsma, M. F., & Spek, C. A. (2020) · BMC Cancer · doi:10.1186/s12885-020-07697-1 · Cited by 42
Weight Loss as an Untapped Early Detection Marker in Pancreatic and Periampullary Cancer
Hue, J. J., Sugumar, K., Kyasaram, R. K., Shanahan, J., Lyons, J. L., Ocuin, L. M., Rothermel, L. D., Hardacre, J. M., Ammori, J. B., Rao, G., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-09861-8 · Cited by 39
Berry, W., Algar, E. M., Kumar, B., Desmond, C., Swan, M. P., Jenkins, B. J., & Croagh, D. G. (2017) · International Journal of Cancer · doi:10.1002/ijc.30648 · Cited by 40
AGA Guidelines for the Management of Pancreatic Cysts
Lennon, A. M., Ahuja, N., & Wolfgang, C. L. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.062 · Cited by 39
Miura, S., Takikawa, T., Kikuta, K., Hamada, S., Kume, K., Yoshida, N., Tanaka, Y., Matsumoto, R., Ikeda, M., Kataoka, F., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11091693 · Cited by 38
Oligometastases/Oligo-Recurrence of Lung Cancer
Niibe, Y., Chang, J. Y., Onishi, H., Salama, J. K., Hiraki, T., & Yamashita, H. (2013) · Pulmonary Medicine · doi:10.1155/2013/438236 · Cited by 39
Biomarker-driven patient selection for early clinical trials
Dienstmann, R., Rodon, J. A., & Tabernero, J. M. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835ff3cb · Cited by 40
Occult Specimen Contamination in Routine Clinical Next-Generation Sequencing Testing
Sehn, J. K., Spencer, D. H., Pfeifer, J. D., Bredemeyer, A. J., Cottrell, C. E., Abel, H., & Duncavage, E. J. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpr88wdjjldmbn · Cited by 38
Saber, A., Hiltermann, T. J. N., Kok, K., Terpstra, M. M., de Lange, K., Timens, W., Groen, H. J. M., & van den Berg, A. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw128 · Cited by 39
Merugu, S., Chen, L., Gavens, E., Gabra, H. O. S., Brougham, M. F. H., Makin, G., Ng, A., Murphy, D., Gabriel, A. S., Robinson, M. L., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0656 · Cited by 38
Yin, Y., Liu, P., Shi, Y., & Li, P. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_47 · Cited by 40
Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators?
Rossmeislová, L., Gojda, J., & Smolková, K. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10016-0 · Cited by 38
Bracci, P. M., Zhou, M., Young, S., & Wiemels, J. L. (2012) · Cancer · doi:10.1002/cncr.27538 · Cited by 38
Insertions and Deletions (Indels)
Sehn, J. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404748-8.00009-5 · Cited by 49
Feingold, P. L., Kwong, M. L. M., Davis, J. L., & Rudloff, U. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24476 · Cited by 38
Kim, E. J.-H., & Simeone, D. M. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328349e31f · Cited by 37
Walker, E. J., Ko, A. H., Holly, E. A., & Bracci, P. M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29120 · Cited by 37
Shi, K., Queiroz, K. C. S., Stap, J., Richel, D. J., & Spek, C. A. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12361 · Cited by 38
Spatial and temporal cancer evolution: causes and consequences of tumour diversity
Hiley, C. T., & Swanton, C. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-6-s33 · Cited by 39
Circulating Metabolites and Survival Among Patients With Pancreatic Cancer
Yuan, C., Clish, C. B., Wu, C. H., Mayers, J. R., Kraft, P. L., Townsend, M. K., Zhang, M., Tworoger, S. S., Bao, Y., Qian, Z. R., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv409 · Cited by 37
Sheng, J. Z., Wang, Y., Xiong, L., Luo, Q., Li, X., Shen, Z., & Zhu, W. (2017) · Polymer Chemistry · doi:10.1039/c6py02243j · Cited by 37
Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling
Niida, A., Nagayama, S., Miyano, S., & Mimori, K. (2018) · Cancer Science · doi:10.1111/cas.13510 · Cited by 37
Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
Chiou, S., Dorsch, M., Kusch, E., Naranjo, S., Kozak, M. M., Koong, A. C., Winslow, M. M., & Grüner, B. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-32159-x · Cited by 37
Potential application of cell reprogramming techniques for cancer research
Saito, S., Lin, Y., Nakamura, Y., Eckner, R., Wuputra, K., Kuo, K., Lin, C., & Yokoyama, K. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2924-7 · Cited by 38
Prevention and Reversion of Pancreatic Tumorigenesis through a Differentiation-Based Mechanism
Krah, N. M., Narayanan, S. M., Yugawa, D. E., Straley, J. A., Wright, C. V. E., MacDonald, R. J., & Murtaugh, L. C. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.07.012 · Cited by 41
Tang, Y., & Cao, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030422 · Cited by 42
Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival
Ulanja, M. B., Moody, A. E., Beutler, B. D., Antwi‐Amoabeng, D., Rahman, G. A., & Alese, O. B. (2022) · Oncotarget · doi:10.18632/oncotarget.28242 · Cited by 38
Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis
Gao, Y., Zhang, S., Zhang, X., Du, Y., Ni, T., & Hao, S. (2024) · iScience · doi:10.1016/j.isci.2024.111359 · Cited by 42
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer
Li, H., Lan, L., Chen, H., Thin, M. Z., Hari, P. S., Nelson, J. K., Evans, I. M., Ruiz, E. J., Cheng, R., Tran, L., et al. (2025) · Nature · doi:10.1038/s41586-025-09574-y · Cited by 41
Kim, T., Jung, S., Kim, M. S., Baek, I.-P., Park, S., Lee, S. H., Lee, H. H., Kim, S. S., Yeun‐Jun, C., & LEE, S. H. (2014) · The Journal of Pathology · doi:10.1002/path.4401 · Cited by 36
miRNA in clinical practice: Pancreatic cancer
Humeau, M., Torrisani, J., & Cordelier, P. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.03.019 · Cited by 36
Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets
Capdevila, J., Meeker, A. K., García‐Carbonero, R., Pietras, K., Astudillo, A., Casanovas, O., & Scarpa, A. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9468-y · Cited by 38
Venous Thromboembolism and Cancer Risk among Elderly Adults in the United States
Marks, M. A., & Engels, E. A. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1138 · Cited by 36
“N of 1” case reports in the era of whole-genome sequencing
Brannon, A. R., & Sawyers, C. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70935 · Cited by 36
A MicroRNA-Based Test Improves Endoscopic Ultrasound–Guided Cytologic Diagnosis of Pancreatic Cancer
Brand, R. E., Adai, A. T., Centeno, B. A., Lee, L., Rateb, G., Vignesh, S., Ménard, C., Wiechowska–Kozłowska, A., Bołdys, H., Hartleb, M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.038 · Cited by 36
Hereditary Pancreatic Cancer Syndromes
Connor, A. A., & Gallinger, S. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.06.007 · Cited by 36
EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis
Tanaka, M. H., Ishikawa, S., Ushiku, T., Morikawa, T., Isagawa, T., Yamagishi, M., Yamamoto, H., Katoh, H., Takeshita, K., Arita, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20601 · Cited by 36
Bartsch, D. K., Krasser‐Gercke, N., Strauch, K., Wieboldt, R., Matthäi, E., Wagner, V., Rospleszcz, S., Schäfer, A., Franke, F. S., Mintziras, I., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100295 · Cited by 36
Dzobo, K., Rowe, A., Senthebane, D. A., AlMazyadi, M., Patten, V. A., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0172 · Cited by 37
Peng, Y., Bi, L., Guo, Y., Feng, D. D., FULHAM, M. J., & Kim, J. (2019) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2019.8857666 · Cited by 36
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?
Tsang, E. S., Topham, J. T., Karasinska, J. M., Lee, M. K. C., Williamson, L., Mendis, S. R., Denroche, R. E., Jang, G. H., Kalloger, S. E., Moore, R. A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1042 · Cited by 37
Self-citationTransitional dynamics of cancer stem cells in invasion and metastasis
Richard, V., Kumar, T. R. S., & Pillai, R. M. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100909 · Cited by 34
Defining Immunogenic and Radioimmunogenic Tumors
Medler, T. R., Blair, T. C., Crittenden, M. R., & Gough, M. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.667075 · Cited by 38
Many Tumors in One: A Daunting Therapeutic Prospect
Ene, C., & Fine, H. A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.018 · Cited by 36
Pathology and genetics of uveal melanoma
Griewank, K., & Murali, R. (2012) · Pathology · doi:10.1097/pat.0b013e32835c6505 · Cited by 36
Delitto, D., Zhang, D., Han, S., Black, B. S., Knowlton, A. E., Vlada, A. C., Sarosi, G. A., Behrns, K. E., Thomas, R. M., Lu, X., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1256 · Cited by 36
Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment
Ansari, D., Frieß, H., Bauden, M. P., Samnegård, J., & Andersson, R. E. (2018) · Oncotarget · doi:10.18632/oncotarget.24019 · Cited by 35
Cancer evolution: the final frontier of precision medicine?
Swanton, C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu005 · Cited by 38
Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases
Bechard, M. E., Word, A. E., Tran, A. V., Liu, X., Locasale, J. W., & McDonald, O. G. (2018) · Oncogene · doi:10.1038/s41388-018-0346-5 · Cited by 35
Bechard, M. E., Smalling, R., Hayashi, A., Zhong, Y., Word, A. E., Campbell, S. L., Tran, A. V., Weiss, V. L., Iacobuzio-Donahue, C., Wellen, K. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17839-5 · Cited by 33
Self-citationHamabe, A., Yamamoto, H., Konno, M., Uemura, M., Nishimura, J., Hata, T., Takemasa, I., Mizushima, T., Nishida, N., Kawamoto, K., et al. (2014) · Cancer Science · doi:10.1111/cas.12487 · Cited by 35
Paterlini-Bréchot, P. (2011) · Future Oncology · doi:10.2217/fon.11.32 · Cited by 37
Individualizing breast cancer treatment—The dawn of personalized medicine
Nandy, A., Gangopadhyay, S., & Mukhopadhyay, A. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.09.002 · Cited by 36
Alteration of pancreatic cancer cell functions by tumor-stromal cell interaction
Hamada, S., Masamune, A., & Shimosegawa, T. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00318 · Cited by 35
Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
Hindriksen, S., & Bijlsma, M. F. (2012) · Cancers · doi:10.3390/cancers4040989 · Cited by 35
Pennec, S. L., Konopka, T., Gacquer, D., Fimereli, D., Tarabichi, M., Tomás, G., Savagner, F., Decaussin‐Petrucci, M., Trésallet, C., Andry, G., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0351 · Cited by 35
Pathogenesis of Pancreatic Cancer
Murtaugh, L. C. (2013) · Toxicologic Pathology · doi:10.1177/0192623313508250 · Cited by 40
Arem, H. E., Mayne, S. T., Sampson, J. N., Risch, H. A., & Stolzenberg‐Solomon, R. Z. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.06.006 · Cited by 35
Molecular Targeted Intervention for Pancreatic Cancer
Mohammed, A., Janakiram, N. B., Pant, S., & Rao, C. V. (2015) · Cancers · doi:10.3390/cancers7030850 · Cited by 34
Sleeping Beauty transposon insertional mutagenesis based mouse models for cancer gene discovery
Moriarity, B. S., & Largaespada, D. A. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.04.007 · Cited by 36
Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo
Chen, S., Zhang, L., Kim, S., Ding, W., Tong, Y., Zhang, X., & Pan, M. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s89805 · Cited by 35
α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15
Kume, K., Ikeda, M., Miura, S., Ito, K., Sato, K. A., Ohmori, Y., Endo, F., Katagiri, H., Ishida, K., Ito, C., et al. (2016) · Scientific Reports · doi:10.1038/srep25895 · Cited by 35
In, G. K., Poorman, K. A., Saul, M. E., O'Day, S. J., Farma, J. M., Olszanski, A. J., Gordon, M. S., Thomas, J. S., Eisenberg, B. L., Flaherty, L. E., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27686 · Cited by 38
McGarry, D. J., Armstrong, G., Castino, G. F., Mason, S. M., Clark, W. A., Shaw, R., McGarry, L., Blyth, K., & Olson, M. F. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.039 · Cited by 35
Pancreatic cancer stem cells: new insights and perspectives
Dorado, J., Lonardo, E., Miranda‐Lorenzo, I., & Heeschen, C. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0422-x · Cited by 35
Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer
Xiao, Z., Luo, G., Liu, C., Wu, C., Liu, L., Liu, Z., Ni, Q., Long, J., & Yu, X. (2014) · BioMed Research International · doi:10.1155/2014/925845 · Cited by 35
Honda, K., & Srivastava, S. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0209 · Cited by 36
Looking beyond drivers and passengers in cancer genome sequencing data
De, S., & Ganesan, S. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw677 · Cited by 36
Lau, D., Leach, M. R., Marca, F. L., & Park, P. (2012) · Journal of Neurosurgery Spine · doi:10.3171/2012.8.spine12449 · Cited by 34
Multilayered molecular profiling supported the monoclonal origin of metastatic renal cell carcinoma
Huang, Y., Gao, S., Wu, S., Song, P., Sun, X., Hu, X., Zhang, S., Yu, Y., Zhu, J., Li, C., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28654 · Cited by 34
Aravindan, S., Ramraj, S. K., Somasundaram, S. T., Herman, T. S., & Aravindan, N. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0173-3 · Cited by 34
New and emerging factors in tumorigenesis: an overview
Kim, S. (2015) · Cancer Management and Research · doi:10.2147/cmar.s47797 · Cited by 34
Urayama, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1707 · Cited by 36
Single-cell analyses of transcriptional heterogeneity in squamous cell carcinoma of urinary bladder
Zhang, X., Zhang, M., Hou, Y., Xu, L., Li, W., Zou, Z., Liu, C., Xu, X., & Wu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11803 · Cited by 35
Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer
Mathot, L., Kundu, S., Ljungström, V., Svedlund, J., Moens, L., Adlerteg, T., Falk-Sörqvist, E., Rendo, V., Bellomo, C., Mayrhofer, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1921 · Cited by 34
de Biase, D., Genestreti, G., Visani, M., Acquaviva, G., Battista, M. D., Cavallo, G., Paccapelo, A., Cancellieri, A., Trisolini, R., Esposti, R. D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177822 · Cited by 34
Kim, J. H., Youn, Y., Kim, K.-T., Jang, G.-B., & Hwang, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-54478-3 · Cited by 33
Guerra, F., Barucca, V., & Coletta, D. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.06.013 · Cited by 34
Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism
O’Leary, B. R., Alexander, M. S., Du, J., Moose, D. L., Henry, M. D., & Cullen, J. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74806-2 · Cited by 35
Pancreatic cancer – the past, the present, and the future
Andersson, R. E., Haglund, C., Seppänen, H. E., & Ansari, D. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2067786 · Cited by 36
Metastasis blood test by flow cytometry: In vivo cancer spheroids and the role of hypoxia
Dénes, V., Lakk, M., Makarovskiy, A. N., Jáksó, P., Szappanos, S., Gráf, L., Mandel, L., Karádi, I., & Geck, P. (2014) · International Journal of Cancer · doi:10.1002/ijc.29155 · Cited by 34
NOP14 promotes proliferation and metastasis of pancreatic cancer cells
Zhou, B., Wu, Q., Chen, G., Zhang, T., & Zhao, Y.-P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.010 · Cited by 34
Biomarker-Based Early Cancer Detection: Is It Achievable?
Hazelton, W. D., & Luebeck, E. G. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003272 · Cited by 34
Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer
Rahbari, M., Rahbari, N. N., Reißfelder, C., Weitz, J., & Kahlert, C. (2016) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-016-1468-2 · Cited by 36
Eckel‐Passow, J. E., Serie, D., Cheville, J. C., Ho, T. H., Kapur, P., Brugarolas, J., Thompson, R. H., Leibovich, B. C., Kwon, E. D., Joseph, R. W., et al. (2017) · BMC Urology · doi:10.1186/s12894-017-0209-3 · Cited by 35
Samain, R., Maiques, Ó., Monger, J., Lam, H., Candido, J. B., George, S. L., Ferrari, N., KohIhammer, L., Lunetto, S., Varela-Vázquez, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi0244 · Cited by 35
Metadata
- Authors
- Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Iacobuzio-Donahue, C. A.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- ORCID
- Venue
- Nature
- Published
- 2010-10
- Volume
- 467
- Issue
- 7319
- Pages
- 1114-1117
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3148940
- OpenAlex
- W2169895148
- Cited by
- 2,502
- References
- 24
- Citations by year
- 2026: 73 · 2025: 84 · 2024: 76 · 2023: 105 · 2022: 122 · 2021: 165 · 2020: 157 · 2019: 147 · 2018: 176 · 2017: 218 · 2016: 208 · 2015: 237 · 2014: 224 · 2013: 182 · 2012: 197
- FWCI
- 50.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5r01ca121113-15)
- U.S. Public Health Service (A62924)
- National Cancer Institute (R01CA140599, CA 57345, R01-CA121113, CA-121113, CA43460, K08CA106610, R37CA043460, R01CA057345, CA106610, P50CA062924, R37CA057345)
- National Institute of General Medical Sciences (R01GM078986, GM078986)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic cancer, distant metastasis, clonal evolution, tumor subclones, chromosomal rearrangements, genomic instability, early detection, tumor heterogeneity, therapeutic target
- MeSH terms
- Adenocarcinoma, Autopsy, Clone Cells, DNA Mutational Analysis, Humans, Liver Neoplasms, Lung Neoplasms, Models, Biological, Mutation, Neoplasm Metastasis, Pancreas, Pancreatic Neoplasms, Peritoneal Neoplasms, Time Factors, Disease Progression, Cell Lineage, Evolution, Molecular, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
